Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarzyna Bożyk

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomedicines|September 28, 2024
Mechanisms of Chimeric Cell Therapy in Duchenne Muscular DystrophyMaria Siemionow, Anna Ziemiecka, Katarzyna Bożyk, et al.
Developmental Biology|May 14, 2017
Mouse↔rat aggregation chimaeras can develop to adulthoodKatarzyna Bożyk, Katarzyna Gilecka, Monika Humięcka, et al.
Biology of Reproduction|September 13, 2019
Attempts to obtain fully xenogeneic fetuses in rat ↔ mouse model†,‡Marcin Szpila, Monika Humięcka, Katarzyna Bożyk, et al.
Stem Cell Reviews and Reports|December 18, 2025
Long-Term Safety and Efficacy of Systemic DT-DEC01 Cell Therapy in Non-Ambulatory Duchenne Muscular Dystrophy Patients: a 24-Month Clinical EvaluationMaria Siemionow, Grzegorz Biegański, Adam Niezgoda, et al.
Archivum Immunologiae Et Therapiae Experimentalis|November 24, 2023
Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic-Intraosseous AdministrationAdam Niezgoda, Grzegorz Biegański, Jacek Wachowiak, et al.
Stem Cell Reviews and Reports|September 14, 2023
Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous AdministrationMaria Siemionow, Grzegorz Biegański, Adam Niezgoda, et al.
The International Journal of Developmental Biology|March 14, 2017
In Memoriam - Prof. Andrzej Krzysztof Tarkowski (1933-2016)Ewa Borsuk, Małgorzata Waksmundzka, Katarzyna Szczepańska, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomedicines|September 28, 2024
Mechanisms of Chimeric Cell Therapy in Duchenne Muscular DystrophyMaria Siemionow, Anna Ziemiecka, Katarzyna Bożyk, et al.
Developmental Biology|May 14, 2017
Mouse↔rat aggregation chimaeras can develop to adulthoodKatarzyna Bożyk, Katarzyna Gilecka, Monika Humięcka, et al.
Biology of Reproduction|September 13, 2019
Attempts to obtain fully xenogeneic fetuses in rat ↔ mouse model†,‡Marcin Szpila, Monika Humięcka, Katarzyna Bożyk, et al.
Stem Cell Reviews and Reports|December 18, 2025
Long-Term Safety and Efficacy of Systemic DT-DEC01 Cell Therapy in Non-Ambulatory Duchenne Muscular Dystrophy Patients: a 24-Month Clinical EvaluationMaria Siemionow, Grzegorz Biegański, Adam Niezgoda, et al.
Archivum Immunologiae Et Therapiae Experimentalis|November 24, 2023
Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic-Intraosseous AdministrationAdam Niezgoda, Grzegorz Biegański, Jacek Wachowiak, et al.
Stem Cell Reviews and Reports|September 14, 2023
Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous AdministrationMaria Siemionow, Grzegorz Biegański, Adam Niezgoda, et al.
The International Journal of Developmental Biology|March 14, 2017
In Memoriam - Prof. Andrzej Krzysztof Tarkowski (1933-2016)Ewa Borsuk, Małgorzata Waksmundzka, Katarzyna Szczepańska, et al.
Pageof 1